The Beauty Health Company (NASDAQ: SKIN) reported Q1 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $81.4 million versus the consensus estimate of $80.54 million.

GUIDANCE:

The Beauty Health Company sees Q2 2024 revenue of $96-102 million, versus the consensus of $108.1 million.

For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.